Robert Millen - Jensen Investment Management Inc
Holding/activity history for Standard Biotools Inc (LAB)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q2 | 0 | 0.00 | Sell 100.00% | 0.05 | SEC | ||
| 2024 Q1 | 32,300 | 0.05 | Reduce 1.25% | <0.01 | $218.46 | $7,056,258 | SEC |
| 2023 Q4 | 32,710 | 0.06 | $227.29 | $7,434,656 | SEC | ||
| 2023 Q3 | 32,710 | 0.05 | Add 2.19% | <0.01 | $201.05 | $6,576,346 | SEC |
| 2023 Q2 | 32,010 | 0.06 | Reduce 3.12% | <0.01 | $241.33 | $7,724,973 | SEC |
| 2023 Q1 | 33,040 | 0.06 | $224.70 | $7,424,088 | SEC | ||
| 2022 Q4 | 33,040 | 0.06 | $235.48 | $7,780,259 | SEC | ||
| 2022 Q3 | 33,040 | 0.06 | Reduce 2.28% | <0.01 | $204.81 | $6,767,000 | SEC |
| 2022 Q2 | 33,810 | 0.07 | Add 8.12% | <0.01 | $234.37 | $7,924,000 | SEC |
| 2022 Q1 | 31,270 | 0.06 | Add 23.11% | 0.01 | $263.67 | $8,245,000 | SEC |
| 2021 Q4 | 25,400 | 0.06 | Add 3.72% | <0.01 | $314.21 | $7,981,000 | SEC |
| 2021 Q3 | 24,490 | 0.05 | Add 21.42% | <0.01 | $281.42 | $6,892,000 | SEC |
| 2021 Q2 | 20,170 | 0.04 | Add 6.10% | <0.01 | $275.86 | $5,564,000 | SEC |
| 2021 Q1 | 19,010 | 0.04 | Add 11.76% | <0.01 | $255.02 | $4,848,000 | SEC |
| 2020 Q4 | 17,010 | 0.03 | Add 53.38% | 0.01 | $203.53 | $3,462,000 | SEC |
| 2020 Q3 | 11,090 | 0.02 | Add 11.79% | <0.01 | $188.28 | $2,088,000 | SEC |
| 2020 Q2 | 9,920 | 0.02 | Add 18.38% | <0.01 | $166.13 | $1,648,000 | SEC |
| 2020 Q1 | 8,380 | 0.01 | Add 1.21% | <0.01 | $126.37 | $1,059,000 | SEC |
| 2019 Q4 | 8,280 | 0.01 | Add 13.74% | <0.01 | $169.20 | $1,401,000 | SEC |
| 2019 Q3 | 7,280 | 0.01 | Add 39.73% | <0.01 | $167.99 | $1,223,000 | SEC |
| 2019 Q2 | 5,210 | 0.01 | Buy | 0.01 | $172.94 | $901,000 | SEC |
| 2014 Q4 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2014 Q3 | 4,710 | 0.01 | Add 1.29% | <0.01 | $101.70 | $479,000 | SEC |
| 2014 Q2 | 4,650 | 0.01 | Reduce 18.28% | <0.01 | $102.37 | $476,000 | SEC |
| 2014 Q1 | 5,690 | 0.01 | Add 20.30% | <0.01 | $98.24 | $559,000 | SEC |
| 2013 Q4 | 4,730 | 0.01 | Add 3.28% | <0.01 | $91.33 | $432,000 | SEC |
| 2013 Q3 | 4,580 | 0.01 | Reduce 99.67% | 2.28 | $99.13 | $454,000 | SEC |
| 2013 Q2 | 1,395,444 | 2.29 | Add 1.58% | 0.04 | $100.10 | $139,684,000 | SEC |
| 2013 Q1 | 1,373,786 | 2.07 | Add 0.77% | 0.02 | $90.20 | $123,915,000 | SEC |
| 2012 Q4 | 1,363,309 | 2.21 | Reduce 2.16% | 0.05 | $86.62 | $118,089,000 | SEC |
| 2012 Q3 | 1,393,399 | 2.31 | Add 1.61% | 0.04 | $92.47 | $128,847,000 | SEC |
| 2012 Q2 | 1,371,324 | 2.31 | Add 0.86% | 0.02 | $92.61 | $126,998,000 | SEC |
| 2012 Q1 | 1,359,573 | 2.15 | Add 36.96% | 0.58 | $91.54 | $124,455,000 | SEC |
| 2011 Q4 | 992,683 | 1.60 | Add 1.67% | 0.03 | $85.97 | $85,340,000 | SEC |
| 2011 Q3 | 976,413 | 0.79 | Buy | 0.79 | $79.05 | $77,185,000 | SEC |